CrowdStrike: The Re-Rating Is Already Paid For

Argus Research just told you the cheap CrowdStrike is gone, probably without meaning to. On Friday morning analyst Joseph Bonner raised his price target on the stock to $425 from $230, keeping a Buy, a day after CrowdStrike reported quarterly results that blew past estimates. It reads as fresh conviction. It is really a timing record: five weeks earlier the same firm was still working from a $200 target — below where the stock already traded — and shares have since more than doubled off the roughly $86 low they touched this spring. Argus is catching up, not leading.

To see why that matters, it helps to relive the fear that made the cheap shares exist in the first place. CrowdStrike spent 2025 under a shadow — still recovering from the mid-2024 global IT outage, with a forecast that disappointed and growth that kept decelerating. Then in early 2026 the market found a scarier story: Anthropic's new AI tools, which scan code for vulnerabilities themselves, triggered a selloff across cybersecurity on worries that AI applied to security would hollow out the traditional platform vendors. At the worst of it this spring, the shares printed a 52-week low near $86 while customers kept paying.

The panic was the setup. The cash flow made it a finished trade. Underneath the fear, CrowdStrike's free cash flow has kept compounding: over the last twelve months it generated about $1.5 billion of free cash flow, up roughly 47% year over year on a free cash flow margin near 28%, against a balance sheet with roughly $5 billion of cash. Wednesday's second-quarter report made the inflection explicit — record net new ARR of about $333 million, up 51% year over year; ending annual recurring revenue of $5.84 billion, up 25%; and Falcon Flex, the flexible licensing vehicle that has become the funnel for AI-security budgets, up 101% to $2.29 billion of ARR. CEO George Kurtz called it "the best quarter in CrowdStrike's history," and the company raised its fiscal-2027 net-new-ARR growth guidance twice in two quarters, to 34% at the midpoint, with revenue guided near $6 billion.

Now put a number on what the market charges for that proof. CrowdStrike trades within about 5% of its 52-week high, up more than 85% this year, at a market capitalization near $223 billion and an enterprise value near $219 billion. That is roughly 40 times trailing revenue and, against the company's own cash generation, about 140 times trailing free cash flow. Even a full year of that raised guidance — which implies another step up in cash generation — still leaves the cash-flow multiple in triple digits. To get that multiple down to a merely rich 50 times, the company would need to roughly triple its free cash flow, which at a 40%-plus compounding clip takes about three years. The market is not paying for the turn anymore; it is paying years of proof in advance.

That is the honest difference between this spring and now. At the $86 low, the market was pricing an old story — AI extinction, stagnation — against improving numbers, the exact setup that pays when the trajectory turns before the crowd believes it. That entry consumed the reset. Everything since — Argus at $230, then $425; a mean street target sitting near $195 in mid-July, below the tape — is the crowd confirming a move that already happened.

The asterisk on the bull case is that GAAP profitability is still thin: second-quarter GAAP earnings per share were a penny, because stock-based compensation eats the gap the non-GAAP number waves away. Non-GAAP EPS guidance of $1.25 to $1.26 for the fiscal year still leaves the stock near 170 times "earnings" on that basis. The four-for-one split this summer made the ticket price friendlier to momentum, not to value.

None of this says the business is bad. It is demonstrably good and getting better: the proof point for the next twelve months is alive, with net-new-ARR growth guided to 34% and free cash flow compounding faster than revenue. What must keep happening for a triple-digit cash-flow multiple to hold is that growth staying in the 30s or better while the free cash flow margin holds near 28%. What breaks the thesis is also concrete: net-new-ARR growth rolling over into the mid-20s, the free cash flow margin compressing, stock compensation diluting faster than cash compounds, or a security event like 2024's — the one variable no multiple can model.

The useful lesson here is not about Argus's target, it is about what has already been paid. At the spring low the market priced extinction against rising cash flow, and the cash flow won — twice over, in the share price and in the target sheets. The cheapest CrowdStrike was the one nobody wanted, when skepticism was still pricing the old risk while the operating setup was already getting cleaner. At $218 the discount is gone, the crowd has arrived, and every new dollar pre-pays years of compounding the company still has to deliver. I can be wrong again — CrowdStrike has already humbled everyone who sold the panic. But the honest frame is that the inflection is no longer ahead of the consensus; it is behind it. What is left is a harder calculus: how many years of 30%-plus growth you are willing to fund in advance, and what you will do the quarter a stumble hands the argument back to the bears.